[go: up one dir, main page]

ATE193529T1 - Pyrrolidinyldicarbonsäure-derivate zur verwendung als metabotrope glutamat-rezeptor-antagonisten - Google Patents

Pyrrolidinyldicarbonsäure-derivate zur verwendung als metabotrope glutamat-rezeptor-antagonisten

Info

Publication number
ATE193529T1
ATE193529T1 AT95308031T AT95308031T ATE193529T1 AT E193529 T1 ATE193529 T1 AT E193529T1 AT 95308031 T AT95308031 T AT 95308031T AT 95308031 T AT95308031 T AT 95308031T AT E193529 T1 ATE193529 T1 AT E193529T1
Authority
AT
Austria
Prior art keywords
pyrrolidinyldicarbonic
acid derivatives
receptor antagonists
glutamate receptor
metabotropic glutamate
Prior art date
Application number
AT95308031T
Other languages
English (en)
Inventor
James Allen Monn
Darryle Darwin Schoepp
Matthew John Valli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE193529T1 publication Critical patent/ATE193529T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT95308031T 1994-11-14 1995-11-09 Pyrrolidinyldicarbonsäure-derivate zur verwendung als metabotrope glutamat-rezeptor-antagonisten ATE193529T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/337,801 US5473077A (en) 1994-11-14 1994-11-14 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists

Publications (1)

Publication Number Publication Date
ATE193529T1 true ATE193529T1 (de) 2000-06-15

Family

ID=23322078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95308031T ATE193529T1 (de) 1994-11-14 1995-11-09 Pyrrolidinyldicarbonsäure-derivate zur verwendung als metabotrope glutamat-rezeptor-antagonisten

Country Status (9)

Country Link
US (1) US5473077A (de)
EP (1) EP0711755B1 (de)
JP (1) JPH10508855A (de)
AT (1) ATE193529T1 (de)
AU (1) AU4281896A (de)
CA (1) CA2204767A1 (de)
DE (1) DE69517286T2 (de)
ES (1) ES2146718T3 (de)
WO (1) WO1996015108A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607973A (en) * 1995-06-28 1997-03-04 Theriault; Elizabeth Method of treating traumatic CNS tissue injury with a metabotropic glutamate receptor agonist
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
BR9913701A (pt) * 1998-09-14 2001-06-05 Warner Lambert Co ácidos alquil pirrolidina-3-carboxìlicos ramificados
US20040082783A1 (en) * 2002-08-06 2004-04-29 Schafmeister Christian E. Bis (amino acid) molecular scaffolds
WO2005030128A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Pyrazole modulators of metabotropic glutamate receptors
EP1604978A1 (de) * 2004-06-02 2005-12-14 Faust Pharmaceuticals Trans Pyrrolidinylderivate und ihre pharmazeutische Verwendung
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP2275096A3 (de) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AR059898A1 (es) * 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
AU2007249435A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 HT receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
BRPI0716604A2 (pt) * 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
WO2009033703A1 (en) * 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
ATE516272T1 (de) 2007-09-14 2011-07-15 Ortho Mcneil Janssen Pharm 1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
RS51660B (sr) 2007-09-14 2011-10-31 Ortho-Mcneil-Janssen Pharmaceuticals Inc. 1`,3`-disupstituisani-4-fenil-3,4,5,6-tetrahidro-2h, 1`h-[1,4`] bipiridinil-2`-oni
EP2220083B1 (de) * 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]-pyridin-derivate und ihre verwendung als positive allosterische modulatoren von mglur2-rezeptoren
EP2344470B1 (de) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexylderivate als modulatoren von metabotropen glutamatrezeptoren
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
KR20120035158A (ko) 2009-05-12 2012-04-13 얀센 파마슈티칼즈, 인코포레이티드 1,２,４?트리아졸로［４,３?ａ］피리딘 유도체 및 ｍＧｌｕＲ２ 수용체의 양성 알로스테릭 조절자로서의 그의 용도
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
JP5709101B2 (ja) * 2010-09-01 2015-04-30 東レ・ファインケミカル株式会社 ヒドロキシプロリン誘導体の製造法
CA2814996C (en) 2010-11-08 2019-10-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2643320B1 (de) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridinderivate und ihre verwendung als positiv allosterische modulatoren des mglur2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
CN109999033B (zh) 2014-01-21 2022-12-23 詹森药业有限公司 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
HRP20191646T1 (hr) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
US9856231B2 (en) * 2015-03-09 2018-01-02 Northwestern University Tetrahydrothiophene-based GABA aminotransferase inactivators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140696A (en) * 1973-08-22 1979-02-20 Gruppo Lepetit S.P.A. Aminopyrrole derivatives
US3976660A (en) * 1974-08-15 1976-08-24 E. R. Squibb & Sons, Inc. Pyrrolidine derivatives
AU6739390A (en) * 1989-10-25 1991-05-31 Regents Of The University Of California, The Method of inhibiting the transport of l-glutamate
DE4134756A1 (de) * 1991-10-22 1993-04-29 Bayer Ag Verwendung von teilweise bekannten substituierten pyrrolidinen als arzneimittel, neue wirkstoffe und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE69517286D1 (de) 2000-07-06
ES2146718T3 (es) 2000-08-16
CA2204767A1 (en) 1996-05-23
AU4281896A (en) 1996-06-06
DE69517286T2 (de) 2001-02-22
US5473077A (en) 1995-12-05
WO1996015108A1 (en) 1996-05-23
JPH10508855A (ja) 1998-09-02
EP0711755A1 (de) 1996-05-15
EP0711755B1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
ATE193529T1 (de) Pyrrolidinyldicarbonsäure-derivate zur verwendung als metabotrope glutamat-rezeptor-antagonisten
ATE230732T1 (de) Imidazol-derivate mit biphenylsulfonylharnstoff- oder biphenylsulfonylurethan-seitenkette, verfahren zu ihrer herstellung und ihre verwendung
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
ATE219077T1 (de) Endothelin antagoniste
NO983189L (no) Nye substituerte imidazolforbindelser
ATE217873T1 (de) Pyrrolopyrimidinen und verfahren zu deren herstellung
NO964236L (no) Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
ATE284853T1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
ATE211139T1 (de) Tetrahydroimidazopyridoindoldione als cgmp spezifische pde hemmer
ATE168678T1 (de) Heterozyklische derivate als plätchenaggregationsinhibitoren
DE59702414D1 (de) Dipeptidische benzamidine als kininogenasen-inhibitoren
DE69705930D1 (de) Neue n-(arylsulfonyl)aminosäurederivate mit einer affinität für bradykininrezeptoren
ES2162825T3 (es) Derivados de piperazina.
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
DE69633943D1 (de) Morphine derivate mit analgetischen eigenschaften
TR199800531T1 (xx) NMDA antagonistleri olarak tetrahidrokinolinler.
LV11899A (lv) Jauni adenozina atvasinajumi to iegusanas panemiens
ATE258438T1 (de) Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
EA199800380A1 (ru) Антагонисты рецептора возбуждающих аминокислот
FI930236A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
BG104022A (en) New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
ATE231510T1 (de) Penamsulfone als beta-laktamase inhibitoren
ATE392413T1 (de) Verfahren zur herstellung von beta-alaninamiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties